UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM SD

 

 

Specialized Disclosure Report

 

 

NATUS MEDICAL INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		000–33001		77–0154833
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)
1501 Industrial Road, San Carlos, California				94070
(Address of principal executive offices)				(Zip Code)

Jonathan A. Kennedy, Sr. VP, CFO

(650) 802–0400

(Name and telephone number, including area code, of the person to contact in connection with this report.)

 

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

x	Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2013.

 

 

 

---

Section 1 – Conflict Minerals Disclosure

Item 1.01

The Company has filed a Conflict Minerals Report, which appears as Exhibit 1.02 hereto and is publicly available at http://www.natus.com

Item 1.02 Exhibit

A copy of the Company’s Conflict Minerals Report is provided as Exhibit 1.02 hereto.

Section 2 – Exhibits

Item 2.01 Exhibits

Exhibit 1.02 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

Natus Medical Incorporated
(Registrant)
		/s/ Jonathan A. Kennedy
By:		Jonathan A. Kennedy, Senior Vice President Finance and Chief Financial Officer
Date:		June 2, 2014